3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
14
Phase 3
4
Phase 1
2
Phase 4
1
Phase 2/3
1
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
6
Lymphoid
6
Plasma cell
1
Classical hematology
1
Breast
1
Conditions
Leukemia, Myeloid, Acute
1
Febrile Neutropenia
1
Interventions
fludarabine phosphate
3
Filgrastim
3
Cyclophosphamide
3
eltrombopag
2
Radiotherapy
2
Methylprednisolone
2
Melphalan
2
Cytarabine
2
Busulfan
2
Azacitidine
2
Antilymphocyte Serum
2
venetoclax
1
tipifarnib
1
cedazuridine
1
Whole-Body Irradiation
1
Thiotepa
1
Tacrolimus
1
Rivaroxaban
1
Methotrexate
1
Immunologic Techniques
1
Granulocyte Colony-Stimulating Factor
1
Gene Expression Profiling
1
Gemtuzumab
1
Etoposide
1
Daunorubicin
1
Darbepoetin alfa
1
DNA Methylation
1
Cytogenetic Analysis
1
Cyclosporine
1
Clofarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Granulocyte Colony-Stimulating Factor
×
Classical hematology
×
Clear all
NCT02427919
2015-04-28
DeGREE
Seoul St. Mary's Hospital
Phase 2/3
Unknown
56 enrolled